Shu‐Kui Qin; Qing Li; Jian Ming Xu; Jun Liang; Ying Cheng; Ying Fan; Jun Jiang; Hao Ye; Huimin Tao; Lian Li; Limin Zheng; Zhaohui Wei; Shu Li; Kun Meng; Bin Ye; Yan Sun

Manipulation of Regulatory Cells’ Responses to Treatments for Chronic Hepatitis B Virus Infection

Hepatitis Monthly 16(6) (2016)

Soheil Tavakolpour; Seyed Moayed Alavian; Shahnaz Sali

Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis

Hepatitis Monthly 16(4) (2016)

Soheil Tavakolpour; Shahnaz Sali

Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment

Asian Pacific Journal of Cancer Prevention 22(9) (2021)

Shahab Mahmoudvand; Somaya Shokri; Habibollah Mirzaei; Ali Ramazani; Manoochehr Makvandi; Nilofar Neisi; Sayed Jalal Hashemi

Iranian guideline for rituximab therapy in pemphigus patients

Dermatologic Therapy 32(5) (2019)

Maryam Daneshpazhooh; Kamran Balighi; Hamidreza Mahmoudi; Soheil Tavakolpour; Robabeh Abedini; Tahereh Soori; Amir‐Houshang Ehsani; Maryam Ghiasi; Pedram Noormohammadpour; Narges Ghandi; Vahideh Lajevardi; Ali Sadeghinia; Maryam Nasimi; Arghavan Azizpour; Cheyda Chams‐Davatchi

Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

Archives of Dermatological Research 310(2) (2017)

Soheil Tavakolpour

Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences

Expert Opinion on Biological Therapy 17(8) (2017)

Priyanka Vashisht; James O’dell

Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy

Immunology Letters 190 (2017)

Soheil Tavakolpour; Hajar Sadat Mirsafaei; Somayeh Elkaei Behjati; Mojtaba Ghasemiadl; Meisam Akhlaghdoust; Shahnaz Sali

Liver Illness and Psoriatic Patients

BioMed Research International 2018 (2018)

Marco Fiore; Sebastiano Leone; Alberto Enrico Maraolo; Emilio Berti; Giovanni Damiani

Recommendations for the treatment of hepatitis B in 2017

Clinical and Experimental Hepatology 2 (2017)

Robert Flisiak; Waldemar Halota; Jerzy Jaroszewicz; Jacek Juszczyk; Piotr Małkowski; Małgorzata Pawłowska; Anna Piekarska; Krzysztof Simon; Krzysztof Tomasiewicz; Marta Wawrzynowicz-Syczewska

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

Blood 133(2) (2019)

Shigeru Kusumoto; Luca Arcaini; Xiaonan Hong; Jie Jin; Won Seog Kim; Yok Lam Kwong; Marion G. Peters; Yasuhito Tanaka; Andrew D. Zelenetz; Hiroshi Kuriki; Günter Fingerle-Rowson; Tina Nielsen; Eisuke Ueda; Hanna Piper-Lepoutre; Gila Sellam; Kensei Tobinai

SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection

Journal of Clinical Virology Plus 3(4) (2023)

Shahrzad Shoraka; Seyed Reza Mohebbi; Seyed Masoud Hosseini; Amir Ghaemi; Mohammad Reza Zali

Immune response to occult hepatitis B virus infection among hemodialysis patients: A review

The Microbe 5 (2024)

Ali Mussa; Nor Hayati Ismail; Nazmul Huda Syed; Mustafa Talib; Alaa Siddig; Rosline Hassan; Rohimah Mohamud; Nik Haszroel Hysham Nik Hashim

Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT

iScience 26(3) (2023)

Jinhua Ren; QiaoXian Lin; Qi Chen; Jingjing Xu; Dabin Chen; Renli Chen; Kangni Lin; Haojie Zhu; Chenjing Ye; Xiaofeng Luo; Shaozhen Chen; Hui Kong; Qiong Lin; Nan Li; Xu Lin; Zhizhe Chen; Jianda Hu; Ting Yang

Hepatitis B reactivation in chronic hepatitis C patients treated with interferon or pan‐oral direct‐acting antivirals

Hepatology 67(1) (2017)

Jiaye Liu

Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study

World Journal of Virology 13(1) (2024)

Nayana Sudevan; Manish Manrai; T V S V G K Tilak; Harshit Khurana; Harikrishnan Premdeep

Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens

World Journal of Gastroenterology 30(44) (2024)

Rui Lu; Meng Zhang; Zi-Han Liu; Miao Hao; Yan Tian; Mei Li; Feng-Ping Wu; Wen-Jun Wang; Juan-Juan Shi; Xin Zhang; Xiao-Li Jia; Zi-Cheng Jiang; Xue-Mei Li; Guang-Hua Xu; Ya-Ping Li; Shuang-Suo Dang

Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus

Journal of Clinical and Translational Hepatology 4(4) (2016)

The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence

Cancer Treatment Reviews 86 (2020)

G. Tapia Rico; M.M. Chan; K.F. Loo

Immune phase transition under steroid treatment

Physical Review E 103(6) (2021)

Sonali Priyadarshini Nayak; Susmita Roy

Anti-TNF alfa kullanan hastalarda hepatit B reaktivasyonunun değerlendirilmesi

Dicle Tıp Dergisi 46(3) (2019)

İlkay BOZKURT; Ahmet BEKTAŞ

Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study

Infection and Drug Resistance Volume 15 (2022)

Pei He; Jie Xia; Peixin Zhang; Wensu Yang; Zhaoxin Xia; Ping Liu; Yi Zhu; Yaping Fang; Zhenhua Zhang; Jilu Shen

Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort study

Journal of Infection and Chemotherapy 27(10) (2021)

Hitoshi Yonezawa; Shingo Tanaka; Momoko Furuya; Koji Yamada; Koichi Asanuma; Yoshihiro Fujiya; Koji Miyanishi; Satoshi Takahashi; Junji Kato

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma

Journal of Investigative Medicine High Impact Case Reports 5(2) (2017)

Alisse Hannaford; David Del Bello; Siyang Leng; Ajai Chari; Ponni Perumalswami; Douglas Dieterich; Andrea Branch

Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19

Pathogens 11(5) (2022)

Caterina Sagnelli; Antonello Sica; Massimiliano Creta; Alessandra Borsetti; Massimo Ciccozzi; Evangelista Sagnelli

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

PLOS ONE 12(9) (2017)

María Buti; María L. Manzano; Rosa M. Morillas; Montserrat García-Retortillo; Leticia Martín; Martín Prieto; María L. Gutiérrez; Emilio Suárez; Mariano Gómez Rubio; Javier López; Pilar Castillo; Manuel Rodríguez; José M. Zozaya; Miguel A. Simón; Luis E. Morano; José L. Calleja; María Yébenes; Rafael Esteban

Anti-Rheumatic Therapy and Comorbidity

Comorbidity in Rheumatic Diseases (2017)

J. Steuart Richards; Sharon Dowell; Mercedes Quinones